LSTA (Lisata Therapeutics, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by LSTA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-13 | MOHAMMAD AZAB | Director | A | — | — |
| 2026-01-13 | STEVEN M KLOSK | Director | A | — | — |
| 2026-01-13 | Cynthia Louise Flowers | Director | A | — | — |
| 2026-01-13 | James Nisco | SVP, Fin/Treas, Chief Actg Off | MIXED | — | — |
| 2026-01-13 | HEIDI HENSON | Director | A | — | — |
| 2026-01-13 | GREGORY B BROWN | Director | A | — | — |
| 2026-01-13 | David J Mazzo | President & CEO | MIXED | — | — |
| 2026-01-13 | Tariq Imam | SVP, Bus Dev, General Counsel | MIXED | — | — |
| 2026-01-13 | Kristen K Buck | EVP, R&D and CMO | MIXED | — | — |
| 2025-01-13 | MOHAMMAD AZAB | Director | A | — | — |
| 2025-01-13 | STEVEN M KLOSK | Director | A | — | — |
| 2025-01-13 | David J Mazzo | President & CEO | MIXED | — | — |
| 2025-01-13 | Kristen K Buck | EVP, R&D and CMO | MIXED | — | — |
| 2025-01-13 | Cynthia Louise Flowers | Director | A | — | — |
| 2025-01-13 | HEIDI HENSON | Director | A | — | — |
| 2025-01-13 | GREGORY B BROWN | Director | A | — | — |
| 2025-01-13 | James Nisco | SVP, Fin/Treas, Chief Actg Off | MIXED | — | — |
| 2024-10-02 | David J Mazzo | President & CEO | MIXED | — | — |
| 2024-10-02 | James Nisco | SVP, Fin/Treas, Chief Actg Off | MIXED | — | — |
| 2024-10-02 | Kristen K Buck | EVP, R&D and CMO | MIXED | — | — |
| 2024-01-12 | David J Mazzo | Chief Executive Officer | F | — | — |
| 2024-01-11 | STEVEN M KLOSK | Director | A | — | — |
| 2024-01-11 | HEIDI HENSON | Director | A | — | — |
| 2024-01-11 | GREGORY B BROWN | Director | A | — | — |
| 2024-01-11 | MOHAMMAD AZAB | Director | A | — | — |
| 2024-01-11 | Cynthia Louise Flowers | Director | A | — | — |
| 2024-01-11 | David J Mazzo | Chief Executive Officer | MIXED | — | — |
| 2024-01-11 | Kristen K Buck | EVP, R&D and CMO | MIXED | — | — |
| 2023-09-05 | Kristen K Buck | EVP, R&D and CMO | F | — | — |
| 2023-01-17 | David J Mazzo | Chief Executive Officer | F | — | — |
| 2023-01-12 | David J Mazzo | Chief Executive Officer | F | — | — |
| 2023-01-11 | HEIDI HENSON | Director | A | — | — |
| 2023-01-11 | Erkki Ruoslahti | Director | A | — | — |
| 2023-01-11 | STEVEN M KLOSK | Director | A | — | — |
| 2023-01-11 | Cynthia Louise Flowers | Director | A | — | — |
| 2023-01-11 | MOHAMMAD AZAB | Director | A | — | — |
| 2023-01-11 | Kristen K Buck | EVP, R&D and CMO | MIXED | — | — |
| 2023-01-11 | David J Mazzo | Chief Executive Officer | MIXED | — | — |
| 2023-01-11 | David W. Slack | President & CBO | MIXED | — | — |
| 2023-01-11 | GREGORY B BROWN | Director | A | — | — |
| 2022-09-16 | MOHAMMAD AZAB | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 1,191,144 | — |
| — | President & CEO | 319,744 | — |
| — | Director | 104,925 | — |
| — | Director | 95,815 | — |
| — | Director | 95,659 | — |
| — | EVP, R&D and CMO | 95,609 | — |
| — | Director | 95,446 | — |
| — | Director | 85,725 | — |
| — | SVP, Bus Dev, General Counsel | 38,178 | — |
| — | SVP, Fin/Treas, Chief Actg Off | 32,311 | — |
| — | President & CBO | 24,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the LSTA quote page; the site-wide leaderboard is on the insider transactions hub.